Physician profile
Christopher L Peters
NPI 1407946023
$7,608,388.24
in general payments reported to CMS, 2019-2025
4 companies · $1.4M in 2025
The $1.4M reported for 2025 was more than what 99% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $924K · 2020: $823K · 2021: $894K · 2022: $1.0M · 2023: $1.2M · 2024: $1.3M · 2025: $1.4M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.2M · Consulting Fee: $1.4M · Acquisitions: $230K · Education: $49K · Travel and Lodging: $34K · Food and Beverage: $5,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,163,942.61 |
| Consulting Fee | $1,441,449.57 |
| Acquisitions | $229,686.56 |
| Education | $48,919.00 |
| Travel and Lodging | $34,422.44 |
| Food and Beverage | $5,249.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $7,583,433.91 | 2019-2025 | Vanguard Complete Knee Solution, Persona, Rosa |
| Smith+Nephew, INC. | $20,049.54 | 2023-2024 | Journey II, Legion Revision, Real Intelligence |
| Synthes Gmbh | $4,520.48 | 2019 | |
| Stryker Corporation | $384.31 | 2019-2023 | Triathlon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Peters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.